Anti-metastatic potential of human V delta 1(+) gamma delta T cells in an orthotopic mouse xenograft model of colon carcinoma

作者：Devaud Christel; Rousseau Benoit; Netzer Sonia; Pitard Vincent; Paroissin Christian; Khairallah Camille; Costet Pierre; Moreau Jean Francois; Couillaud Franck; Dechanet Merville Julie; Capone Myriam^*

来源：Cancer Immunology, Immunotherapy, 2013, 62(7): 1199-1210.

DOI：10.1007/s00262-013-1402-1

• Invasive colon carcinoma
• Immunotherapy
• Human gamma delta T cells
• Orthotopic mouse xenograft model
• Bioluminescence imaging

The role of human intraepithelial V delta 1(+) gamma delta T cell cytotoxic effectors in the immune surveillance against metastatic colon cancer has never been addressed, despite their reported capacity to infiltrate colon carcinomas and to kill colonic cancer cells in vitro. We previously showed that V delta 1(+) gamma delta T cells are enriched in blood in response to cytomegalovirus (CMV) infection, and that such increase may be protective against epithelial cancers. The objective of the present study was to investigate whether CMV-induced V delta 1(+) gamma delta T lymphocytes could inhibit the propagation of human colon tumors in vivo, in order to evaluate their immunotherapeutic potential in this context. Even though metastases are an important cause of death in various cancers including colorectal cancer (CRC), the anti-metastatic effect of immune effectors has been poorly analyzed. To this purpose, we set up a reliable model of metastatic colon cancer through orthotopic implantation of luciferase-expressing human HT29 cells in immunodeficient mice. Using bioluminescence imaging to follow the outcome of colonic cancer cells, we showed that a systemic treatment with CMV-induced V delta 1(+) gamma delta T cells could not only inhibit primary colon tumor growth but also the emergence of secondary tumor foci in the lungs and liver. Finally, our data lead to propose that V delta 1(+) gamma delta T lymphocytes may directly influence the appearance of metastases independently from their control of primary tumor size. These findings, which extend our previous work, pave the road for the potential manipulation of V delta 1(+) gamma delta T lymphocytes in novel anti-CRC immunotherapeutic protocols.

• 出版日期2013-7